Recombinant Human IL-9 Protein Best Seller
R&D Systems, part of Bio-Techne | Catalog # 209-ILB
Key Product Details
Source
Accession #
Conjugate
Applications
Product Specifications
Source
Gln19-Ile144
Purity
Endotoxin Level
N-terminal Sequence Analysis
Predicted Molecular Mass
SDS-PAGE
Activity
The ED50 for this effect is 0.03-0.3 ng/mL.
Scientific Data Images for Recombinant Human IL-9 Protein
Recombinant Human IL-9 Protein Bioactivity
Recombinant Human IL-9 (Catalog # 209-ILB) induces MO7e human megakaryocytic leukemic cell proliferation. The ED50 for this effect is 0.03-0.3 ng/mL.Formulation, Preparation and Storage
Carrier Free
What does CF mean?CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.
What formulation is right for me?In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.
Carrier: 209-ILB
Formulation | Lyophilized from a 0.2 μm filtered solution in PBS with BSA as a carrier protein. |
Reconstitution | Reconstitute at 100 μg/mL in PBS. |
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Carrier Free: 209-ILB/CF
Formulation | Lyophilized from a 0.2 μm filtered solution in PBS. |
Reconstitution | Reconstitute at 100 μg/mL in PBS. |
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Background: IL-9
References
- Noelle, R.J. and E.C. Nowak (2010) Nat. Rev. Immunol. 10:683.
- Goswami, R. and M.H. Kaplan (2011) J. Immunol. 186:3283.
- Nowak, E.C. et al. (2009) J. Exp. Med. 206:1653.
- Townsend, M.J. et al. (2000) Immunity 13:573.
- Leech, M.D. and R.K. Grencis (2006) J. Immunol. 176:2505.
- Fawaz, L.M. et al. (2007) J. Allergy Clin. Immunol. 120:1208.
- Osterfeld, H. et al. (2010) J. Allergy Clin. Immunol. 125:469.
- Jabeen, R. and M.H. Kaplan (2012) Curr. Opin. Immunol. 24:303.
- Tan, C. et al. (2010) J. Immunol. 185:6795.
- Jager, A. et al. (2009) J. Immunol. 183:7169.
- Elyaman, W. et al. (2009) Proc. Natl. Acad. Sci. USA 106:12885.
- Lu, L.-F. et al. (2006) Nature 442:997.
- Stassen, M. et al. (2000) J. Immunol. 164:5549.
- Yang, Y.-C. et al. (1989) Blood 74:1880.
- Renauld, J.-C. et al. (1990) Cytokine 2:9.
Long Name
Alternate Names
Gene Symbol
UniProt
Additional IL-9 Products
Product Documents for Recombinant Human IL-9 Protein
Product Specific Notices for Recombinant Human IL-9 Protein
For research use only